Look At Analyst Expectations For A Better Read On ImmunityBio Inc (NASDAQ: IBRX)
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of -7.43% and -19.16% over the past three months. IBRX shares are trading -2.73% year to date (YTD), with the 12-month market performance down to -51.27% lower. […]
ImmunityBio Inc (NASDAQ: IBRX) Is Getting Increasingly Hard To Ignore
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of -6.92% and -16.46% over the past three months. IBRX shares are trading 5.08% year to date (YTD), with the 12-month market performance down to -45.21% lower. […]
ImmunityBio Inc (NASDAQ: IBRX) Has Another Chance To Impress You
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of 6.25% and 16.53% over the past three months. IBRX shares are trading 12.89% year to date (YTD), with the 12-month market performance down to -52.31% lower. […]
ImmunityBio Inc (IBRX): Street Finally Waking Up
Currently, there are 852.74M common shares owned by the public and among those 88.78M shares have been available to trade. The company’s stock has a 5-day price change of -9.63% and -3.20% over the past three months. IBRX shares are trading 6.25% year to date (YTD), with the 12-month market performance down to -51.60% lower. […]
ImmunityBio Inc (NASDAQ: IBRX): Hunting Genuine Value In Market Debris
Currently, there are 852.74M common shares owned by the public and among those 88.78M shares have been available to trade. The company’s stock has a 5-day price change of 8.03% and 6.47% over the past three months. IBRX shares are trading 15.63% year to date (YTD), with the 12-month market performance down to -44.88% lower. […]
Some Investing Thoughts On ImmunityBio Inc (NASDAQ: IBRX)
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.78, with 4.36 million shares of worth about $12.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.19% during that period and on March 26, 2025 the price saw a gain […]
Investors Should Take Note Of ImmunityBio Inc (IBRX)
ImmunityBio Inc (IBRX) concluded trading on Wednesday at a closing price of $2.76, with 4.34 million shares of worth about $11.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.92% during that period and on Wednesday the price saw a loss of about […]
Investors Should Take Note Of ImmunityBio Inc (IBRX)
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $2.90, with 4.25 million shares of worth about $12.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.89% during that period and on March 13, 2025 the price saw a gain […]
Now Is A Suitable Moment For A Long-Term Purchase Of ImmunityBio Inc (NASDAQ: IBRX)
Currently, there are 696.83M common shares owned by the public and among those 75.96M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Better Times Ahead For ImmunityBio Inc (NASDAQ: IBRX)?
ImmunityBio Inc (IBRX) concluded trading on Thursady at a closing price of $5.24, with 5.31 million shares of worth about $27.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 208.24% during that period and on Thursady the price saw a gain of about […]
